Pneumonia vaccine price drop for lower-income countries |
Clinical News
eMediNexus Coverage from: 
Pneumonia vaccine price drop for lower-income countries

1 Read Comments                

Lower-income countries across the globe will now have access to life-saving pneumococcal conjugate vaccines for US$ 2 per dose.

This was made possible by a new supply agreement between UNICEF, Gavi’s procurement partner, and the Serum Institute of India (SII). The new price is a 43% reduction from the Gavi price of US$3.50 at the initiation of the Advance Market Commitment (AMC). This supply agreement is the first to include a developing country manufacturer. The Indian manufacturer is going to provide ten million PCV doses to Gavi-supported countries every year over the next ten years… (UNICEF, June 16, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now